Clinical Trials
10 trialsNCT07467629 2026-05-19
QLS5212 for Participants With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Phase 1 Recruiting
NCT07584954 2026-05-13
Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors
ImmunoUrchin
Phase 1 Recruiting
NCT07492173 2026-03-25
Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans
Shandong New Time Pharmaceutical Co., LTD
Phase NA Completed
NCT07441174 2026-02-27
IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors
InxMed (Shanghai) Co., Ltd.
Phase 1/2 Recruiting
NCT07268066 2025-12-18
AMethiST
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Recruiting
NCT07257497 2025-12-02
Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol
West China Hospital
Phase 1 Not yet recruiting
NCT07117461 2025-10-16
A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT07146672 2025-08-28
Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors
Shanghai Cell Therapy Group Co.,Ltd
Phase 1/2 Recruiting
NCT07046780 2025-07-02
A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
NCT07038044 2025-06-26
Safety and Efficacy of an Arginine-Restricted Diet in Patients With Solid Tumors
West China Hospital
Phase 1 Not yet recruiting